AIM - AIM stock dips amid mixed results for post-COVID fatigue therapy
2024-02-08 11:37:46 ET
More on Agios Pharmaceuticals, AIM ImmunoTech, etc.
- CVS Health Corporation (CVS) Q4 2023 Earnings Call Transcript
- CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
- CVS Health Corporation 2023 Q4 - Results - Earnings Call Presentation
- CVS cuts 2024 outlook amid a spike in medical costs
- CVS Health beats top-line and bottom-line estimates; lowers FY24 outlook